The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunity
Open accessAbstract
One antibody for all and all antibodies for one: Antibodies against related flavi-viruses such as dengue (DENV) and West Nile (WNV) can cross-react with Zika virus (ZIKV) and could thereby increase disease severity. Bardina et al. tested whether DENV and WNV antibodies from humans, or even yellow fever vaccination, could enhance ZIKV infection. In a mouse model, low titers of DENV and WNV antibodies enhanced ZIKV viremia, especially in the spinal cord and testes, whereas high titers remained protective. Generally, WNV antibodies were less disease-enhancing than DENV antibodies, and, in macaques, yellow fever vaccination had very little effect. Science , this issue p. 175
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Zika Virus (I). Isolations and serological specificity
Dick, G. W. A., Kitchen, S. F., & Haddow, A. J. (1952) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/0035-9203(52)90042-4 · Cited by 2,692
Lanciotti, R. S., Kosoy, O. L., Laven, J. J., Velez, J. O., Lambert, A. J., Johnson, A. J., Stanfield, S. M., & Duffy, M. R. (2008) · Emerging Infectious Diseases · doi:10.3201/eid1408.080287 · Cited by 2,173
Simmons, C. P., Farrar, J. J., van Vinh Chau, N., & Wills, B. (2012) · New England Journal of Medicine · doi:10.1056/nejmra1110265 · Cited by 1,732
Dengue Viremia Titer, Antibody Response Pattern, and Virus Serotype Correlate with Disease Severity
Vaughn, D. W., Green, S., Kalayanarooj, S., Innis, B. L., Nimmannitya, S., Suntayakorn, S., Endy, T. P., Raengsakulrach, B., Rothman, A. L., Ennis, F. A., et al. (2000) · The Journal of Infectious Diseases · doi:10.1086/315215 · Cited by 1,632
Pathogenesis of dengue: challenges to molecular biology
Halstead, S. (1988) · Science · doi:10.1126/science.239.4839.476 · Cited by 1,614
Musso, D., & Gubler, D. J. (2016) · Clinical Microbiology Reviews · doi:10.1128/cmr.00072-15 · Cited by 1,469
Dejnirattisai, W., Supasa, P., Wongwiwat, W., Rouvinski, A., Barba-Spaeth, G., Duangchinda, T., Sakuntabhai, A., Cao-Lormeau, V.-M., Malasit, P., Rey, F. A., et al. (2016) · Nature Immunology · doi:10.1038/ni.3515 · Cited by 914
Zika Virus Targets Human STAT2 to Inhibit Type I Interferon Signaling
Grant, A., Ponia, S. S., Tripathi, S., Balasubramaniam, V., Miorin, L., Sourisseau, M., Schwarz, M. C., Sánchez-Seco, M. P., Evans, M. J., Best, S. M., et al. (2016) · Cell Host & Microbe · doi:10.1016/j.chom.2016.05.009 · Cited by 797
Self-citationSpecificity, cross-reactivity, and function of antibodies elicited by Zika virus infection
Stettler, K., Beltramello, M., Espinosa, D. A., Graham, V., Cassotta, A., Bianchi, S., Vanzetta, F., Minola, A., Jaconi, S., Mele, F., et al. (2016) · Science · doi:10.1126/science.aaf8505 · Cited by 758
The 3.8 Å resolution cryo-EM structure of Zika virus
Sirohi, D., Chen, Z., Sun, L., Klose, T., Pierson, T. C., Rossmann, M. G., & Kuhn, R. J. (2016) · Science · doi:10.1126/science.aaf5316 · Cited by 738
The Global Ecology and Epidemiology of West Nile Virus
Chancey, C., Grinev, A., Volkova, E., & Rios, M. (2015) · BioMed Research International · doi:10.1155/2015/376230 · Cited by 607
Human antibody responses after dengue virus infection are highly cross-reactive to Zika virus
Priyamvada, L., Quicke, K. M., Hudson, W. H., Onlamoon, N., Sewatanon, J., Edupuganti, S., Pattanapanyasat, K., Chokephaibulkit, K., Mulligan, M. J., Wilson, P. C., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1607931113 · Cited by 587
Kliks, S. C., Nimmanitya, S., Nisalak, A., & Burke, D. S. (1988) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1988.38.411 · Cited by 578
Dai, L., Song, J., Lu, X., Deng, Y.-Q., Musyoki, A. M., Cheng, H., Zhang, Y., Yuan, Y., Song, H., Haywood, J., et al. (2016) · Cell Host & Microbe · doi:10.1016/j.chom.2016.04.013 · Cited by 502
Libraty, D. H., Endy, T. P., Houng, H. H., Green, S., Kalayanarooj, S., Suntayakorn, S., Chansiriwongs, W., Vaughn, D. W., Nisalak, A., Ennis, F. A., et al. (2002) · The Journal of Infectious Diseases · doi:10.1086/340365 · Cited by 494
NS5 of Dengue Virus Mediates STAT2 Binding and Degradation
Ashour, J., Laurent-Rolle, M., Shi, P.-Y., & García-Sastre, A. (2009) · Journal of Virology · doi:10.1128/jvi.02188-08 · Cited by 451
Lethal Antibody Enhancement of Dengue Disease in Mice Is Prevented by Fc Modification
Balsitis, S. J., Williams, K. L., Lachica, R., Flores, D., Kyle, J. L., Mehlhop, E., Johnson, S., Diamond, M. S., Beatty, P. R., & Harris, E. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000790 · Cited by 412
West Nile Virus: Epidemiology and Clinical Features of an Emerging Epidemic in the United States
Hayes, E. B., & Gubler, D. J. (2006) · Annual Review of Medicine · doi:10.1146/annurev.med.57.121304.131418 · Cited by 364
Gaunt, M. W., Sall, A. A., Lamballerie, X. D., Falconar, A. K. I., Dzhivanian, T. I., & Gould, E. A. (2001) · Journal of General Virology · doi:10.1099/0022-1317-82-8-1867 · Cited by 337
Liu, W. J., Wang, X. J., Mokhonov, V. V., Shi, P.-Y., Randall, R., & Khromykh, A. A. (2005) · Journal of Virology · doi:10.1128/jvi.79.3.1934-1942.2005 · Cited by 308
Antigenic Structure of Flavivirus Proteins
Roehrig, J. T. (2003) · Advances in Virus Research · doi:10.1016/s0065-3527(03)59005-4 · Cited by 279
Mazzon, M., Jones, M., Davidson, A., Chain, B., & Jacobs, M. (2009) · The Journal of Infectious Diseases · doi:10.1086/605847 · Cited by 230
Swanstrom, J. A., Plante, J. A., Plante, K. S., Young, E. F., McGowan, E., Gallichotte, E. N., Widman, D. G., Heise, M. T., de Silva, A. M., & Baric, R. S. (2016) · mBio · doi:10.1128/mbio.01123-16 · Cited by 230
Tripathi, S., Balasubramaniam, V. R. M. T., Brown, J. A., Mena, I., Grant, A., Bardina, S. V., Maringer, K., Schwarz, M. C., Maestre, A. M., Sourisseau, M., et al. (2017) · PLOS Pathogens · doi:10.1371/journal.ppat.1006258 · Cited by 229
Self-citationInteraction sites on human IgG-Fc for FcγR: current models
Jefferis, R., & Lund, J. (2002) · Immunology Letters · doi:10.1016/s0165-2478(02)00019-6 · Cited by 220
West Nile Virus among Blood Donors in the United States, 2003 and 2004
Stramer, S. L., Fang, C. T., Foster, G. A., Wagner, A. G., Brodsky, J. P., & Dodd, R. Y. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa044333 · Cited by 217
Self-citationDengue virus antibodies enhance Zika virus infection
Paul, L. M., Carlin, E. R., Jenkins, M. M., Tan, A. L., Barcellona, C. M., Nicholson, C. O., Michael, S. F., & Isern, S. (2016) · Clinical & Translational Immunology · doi:10.1038/cti.2016.72 · Cited by 215
Mouse STAT2 Restricts Early Dengue Virus Replication
Ashour, J., Morrison, J., Laurent-Rolle, M., Belicha-Villanueva, A., Plumlee, C. R., Bernal-Rubio, D., Williams, K. L., Harris, E., Fernandez-Sesma, A., Schindler, C., et al. (2010) · Cell Host & Microbe · doi:10.1016/j.chom.2010.10.007 · Cited by 189
Self-citationEstimated cumulative incidence of West Nile virus infection in US adults, 1999–2010
PETERSEN, L. R., CARSON, P. J., BIGGERSTAFF, B. J., CUSTER, B., BORCHARDT, S. M., & BUSCH, M. P. (2013) · Epidemiology and Infection · doi:10.1017/s0950268812001070 · Cited by 183
Ishikawa, T., Yamanaka, A., & Konishi, E. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.01.040 · Cited by 175
Rescue of the 1947 Zika Virus Prototype Strain with a Cytomegalovirus Promoter-Driven cDNA Clone
Schwarz, M. C., Sourisseau, M., Horesh, M. E., Gray, E. S., Chambers, M. T., Tortorella, D., & Evans, M. J. (2016) · mSphere · doi:10.1128/msphere.00246-16 · Cited by 117
Self-citationBardina, S. V., Michlmayr, D., Hoffman, K. W., Obara, C. J., Sum, J., Charo, I. F., Lu, W., Pletnev, A. G., & Lim, J. K. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500352 · Cited by 112
Self-citationKao, D., Danzer, H., Collin, M., Groß, A., Eichler, J., Štambuk, J., Lauc, G., Lux, A., & Nimmerjahn, F. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.11.027 · Cited by 93
Antibody-Enhanced Infection of Monocytes as the Pathogenetic Mechanism for Severe Dengue Illness
Kliks, S. C. (1990) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1990.6.993 · Cited by 60
Molecular basis of antibody‐mediated neutralization and protection against flavivirus
Dai, L., Wang, Q., Qi, J., Shi, Y., Yan, J., & Gao, G. F. (2016) · IUBMB Life · doi:10.1002/iub.1556 · Cited by 51
Michlmayr, D., Bardina, S. V., Rodriguez, C. A., Pletnev, A. G., & Lim, J. K. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1502452 · Cited by 41
Self-citation
Cited by
The continued threat of emerging flaviviruses
Pierson, T. C., & Diamond, M. S. (2020) · Nature Microbiology · doi:10.1038/s41564-020-0714-0 · Cited by 1,098
Zika Virus Infection — After the Pandemic
Musso, D., Ko, A. I., & Baud, D. (2019) · New England Journal of Medicine · doi:10.1056/nejmra1808246 · Cited by 557
The emergence of Zika virus and its new clinical syndromes
Pierson, T. C., & Diamond, M. S. (2018) · Nature · doi:10.1038/s41586-018-0446-y · Cited by 391
Biochemistry and Molecular Biology of Flaviviruses
Barrows, N. J., Campos, R. K., Liao, K.-C., Prasanth, K. R., Soto-Acosta, R., Yeh, S.-C., Schott-Lerner, G., Pompon, J., Sessions, O. M., Bradrick, S. S., et al. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00719 · Cited by 341
Recurrent Potent Human Neutralizing Antibodies to Zika Virus in Brazil and Mexico
Robbiani, D. F., Bozzacco, L., Keeffe, J. R., Khouri, R., Olsen, P. C., Gazumyan, A., Schaefer-Babajew, D., Avila-Rios, S., Nogueira, L., Patel, R., et al. (2017) · Cell · doi:10.1016/j.cell.2017.04.024 · Cited by 333
Metadata
- Authors
- Bardina, S. V., Bunduc, P., Tripathi, S., Duehr, J., Frere, J. J., Brown, J. A., Nachbagauer, R., Foster, G. A., Krysztof, D., Tortorella, D., Stramer, S. L., García-Sastre, A., Krammer, F., & Lim, J. K.
- Venue
- Science
- Published
- 2017-04-14
- Volume
- 356
- Issue
- 6334
- Pages
- 175-180
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2603610268
- Cited by
- 535
- References
- 36
- FWCI
- 76.82
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.